Recalls / Active ingredient / Lamotrigine
Lamotrigine
6 FDA drug recalls involving the active ingredient “Lamotrigine” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-07-20 | Class III | Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478 | AVKARE Inc. |
| 2021-03-15 | Class II | Lamotrigine Extended-Release Tablets 250 mg 30 Tablets Rx Only NDC 49884-604-11 Manufactured by: Zhejiang Huah | Cardinal Health Inc. |
| 2020-05-28 | Class III | Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 4229 | AVKARE Inc. |
| 2019-12-20 | Class I | Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Hai | Taro Pharmaceuticals U.S.A., Inc. |
| 2018-09-11 | Class II | Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: | Torrent Pharma Inc. |
| 2016-08-19 | Class III | Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem Laboratorie | Unichem Pharmaceuticals Usa Inc |